Skip to main content
Erschienen in: Clinical Neuroradiology 2/2018

01.08.2017 | Correspondence

Multicentric Chordoma

An Uncommon and Incompletely Understood Presentation

verfasst von: Jason R. Jones, Anita Huttner, Ajay Malhotra

Erschienen in: Clinical Neuroradiology | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Excerpt

Chordoma is a rare neoplasm of the neuraxis, long believed to arise from notochord remnants. Its distribution has principally thought to favor the sacrococcygeal region, followed by the skull base and then elsewhere discretely along the spine. Although recent data may challenge this pattern, even more infrequently chordomas are seen arising simultaneously at multiple points along the neuraxis [1]. Very few cases of multicentric chordoma have been reported. A more diffuse pattern complicates treatment strategies for this slowly growing, locally recurrent neoplasm that has historically not responded well to chemotherapy. Recent efforts have sought to better explain the inciting variables that lead to this disease and further efforts will hopefully clarify the cause for the exceedingly rare, diffuse presentation, as well as new molecularly based treatment strategies. …
Literatur
1.
Zurück zum Zitat McMaster ML, Goldstein AM, Bromley CM, Ishibe N, Parry DM. Chordoma: incidence and survival patterns in the United States, 1973–1995. Cancer Causes Control. 2001;12(1):1–11.CrossRefPubMed McMaster ML, Goldstein AM, Bromley CM, Ishibe N, Parry DM. Chordoma: incidence and survival patterns in the United States, 1973–1995. Cancer Causes Control. 2001;12(1):1–11.CrossRefPubMed
2.
Zurück zum Zitat Chambers PW, Schwinn CP. Chordoma. A clinicopathologic study of metastasis. Am J Clin Pathol. 1979;72(5):765–76.CrossRefPubMed Chambers PW, Schwinn CP. Chordoma. A clinicopathologic study of metastasis. Am J Clin Pathol. 1979;72(5):765–76.CrossRefPubMed
3.
Zurück zum Zitat Potluri S, Jefferies SJ, Jena R, Harris F, Burton KE, Prevost AT, Burnet NG. Residual postoperative tumour volume predicts outcome after high-dose radiotherapy for chordoma and chondrosarcoma of the skull base and spine. Clin Oncol (R Coll Radiol). 2011;23(3):199–208.CrossRef Potluri S, Jefferies SJ, Jena R, Harris F, Burton KE, Prevost AT, Burnet NG. Residual postoperative tumour volume predicts outcome after high-dose radiotherapy for chordoma and chondrosarcoma of the skull base and spine. Clin Oncol (R Coll Radiol). 2011;23(3):199–208.CrossRef
5.
Zurück zum Zitat Anderson WB, Meyers HI. Multicentric chordoma. Report of a case. Cancer. 1968;21(1):126–8.CrossRefPubMed Anderson WB, Meyers HI. Multicentric chordoma. Report of a case. Cancer. 1968;21(1):126–8.CrossRefPubMed
6.
Zurück zum Zitat Uggowitzer MM, Kugler C, Groell R, Lindbichler F, Radner H, Sutter B, Ranner G. Drop metastases in a patient with a chondroid chordoma of the clivus. Neuroradiology. 1999;41(7):504–7.CrossRefPubMed Uggowitzer MM, Kugler C, Groell R, Lindbichler F, Radner H, Sutter B, Ranner G. Drop metastases in a patient with a chondroid chordoma of the clivus. Neuroradiology. 1999;41(7):504–7.CrossRefPubMed
7.
Zurück zum Zitat Aydin AL, Sasani M, Oktenoglu T, Solaroglu I, Ozer AF. A case of chordoma invading multiple neuroaxial bones: report of ten years follow up. Turk Neurosurg. 2013;23(4):551–6.PubMed Aydin AL, Sasani M, Oktenoglu T, Solaroglu I, Ozer AF. A case of chordoma invading multiple neuroaxial bones: report of ten years follow up. Turk Neurosurg. 2013;23(4):551–6.PubMed
8.
Zurück zum Zitat Grossbach A, Baimeedi P, McDonald W, Bergman T. Multicentric chordoma: a case report and review of the literature. Neurosurgery. 2011;69(6):E1327–E32.CrossRefPubMed Grossbach A, Baimeedi P, McDonald W, Bergman T. Multicentric chordoma: a case report and review of the literature. Neurosurgery. 2011;69(6):E1327–E32.CrossRefPubMed
9.
Zurück zum Zitat Tamaki M, Aoyagi M, Kuroiwa T, Yamamoto M, Kishimoto S, Ohno K. Clinical course and autopsy findings of a patient with clival chordoma who underwent multiple surgeries and radiation during a 10-year period. Skull Base. 2007;17(5):331–40.CrossRefPubMedPubMedCentral Tamaki M, Aoyagi M, Kuroiwa T, Yamamoto M, Kishimoto S, Ohno K. Clinical course and autopsy findings of a patient with clival chordoma who underwent multiple surgeries and radiation during a 10-year period. Skull Base. 2007;17(5):331–40.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Casali PG, Stacchiotti S, Sangalli C, Olmi P, Gronchi A. Chordoma. Curr Opin Oncol. 2007;19(4):367–70.CrossRefPubMed Casali PG, Stacchiotti S, Sangalli C, Olmi P, Gronchi A. Chordoma. Curr Opin Oncol. 2007;19(4):367–70.CrossRefPubMed
11.
Zurück zum Zitat Uhl M, Mattke M, Welzel T, Roeder F, Oelmann J, Habl G, Jensen A, Ellerbrock M, Jäkel O, Haberer T, Herfarth K, Debus J. Highly effective treatment of skull base chordoma with carbon ion irradiation using a raster scan technique in 155 patients: first long-term results. Cancer. 2014;120(21):3410–7.CrossRefPubMed Uhl M, Mattke M, Welzel T, Roeder F, Oelmann J, Habl G, Jensen A, Ellerbrock M, Jäkel O, Haberer T, Herfarth K, Debus J. Highly effective treatment of skull base chordoma with carbon ion irradiation using a raster scan technique in 155 patients: first long-term results. Cancer. 2014;120(21):3410–7.CrossRefPubMed
12.
Zurück zum Zitat Casali PG, Messina A, Stacchiotti S, Tamborini E, Crippa F, Gronchi A, Orlandi R, Ripamonti C, Spreafico C, Bertieri R, Bertulli R, Colecchia M, Fumagalli E, Greco A, Grosso F, Olmi P, Pierotti MA, Pilotti S. Imatinib mesylate in chordoma. Cancer. 2004;101(9):2086–97.CrossRefPubMed Casali PG, Messina A, Stacchiotti S, Tamborini E, Crippa F, Gronchi A, Orlandi R, Ripamonti C, Spreafico C, Bertieri R, Bertulli R, Colecchia M, Fumagalli E, Greco A, Grosso F, Olmi P, Pierotti MA, Pilotti S. Imatinib mesylate in chordoma. Cancer. 2004;101(9):2086–97.CrossRefPubMed
13.
Zurück zum Zitat Stacchiotti S, Marrari A, Tamborini E, Palassini E, Virdis E, Messina A, Crippa F, Morosi C, Gronchi A, Pilotti S, Casali PG. Response to imatinib plus sirolimus in advanced chordoma. Ann Oncol. 2009;20(11):1886–94.CrossRefPubMed Stacchiotti S, Marrari A, Tamborini E, Palassini E, Virdis E, Messina A, Crippa F, Morosi C, Gronchi A, Pilotti S, Casali PG. Response to imatinib plus sirolimus in advanced chordoma. Ann Oncol. 2009;20(11):1886–94.CrossRefPubMed
14.
Zurück zum Zitat Hindi N, Casali PG, Morosi C, Messina A, Palassini E, Pilotti S, Tamborini E, Radaelli S, Gronchi A, Stacchiotti S. Imatinib in advanced chordoma: a retrospective case series analysis. Eur J Cancer. 2015;51(17):2609–14.CrossRefPubMed Hindi N, Casali PG, Morosi C, Messina A, Palassini E, Pilotti S, Tamborini E, Radaelli S, Gronchi A, Stacchiotti S. Imatinib in advanced chordoma: a retrospective case series analysis. Eur J Cancer. 2015;51(17):2609–14.CrossRefPubMed
15.
Zurück zum Zitat Singhal N, Kotasek D, Parnis FX. Response to erlotinib in a patient with treatment refractory chordoma. Anticancer Drugs. 2009;20(10):953–5.CrossRefPubMed Singhal N, Kotasek D, Parnis FX. Response to erlotinib in a patient with treatment refractory chordoma. Anticancer Drugs. 2009;20(10):953–5.CrossRefPubMed
16.
Zurück zum Zitat Yang C, Hornicek FJ, Wood KB, Schwab JH, Choy E, Mankin H, Duan Z. Blockage of Stat3 with CDDO-Me inhibits tumor cell growth in chordoma. Spine (Phila Pa 1976). 2010;35(18):1668-75.CrossRef Yang C, Hornicek FJ, Wood KB, Schwab JH, Choy E, Mankin H, Duan Z. Blockage of Stat3 with CDDO-Me inhibits tumor cell growth in chordoma. Spine (Phila Pa 1976). 2010;35(18):1668-75.CrossRef
17.
Zurück zum Zitat Yang XR, Ng D, Alcorta DA, Liebsch NJ, Sheridan E, Li S, Goldstein AM, Parry DM, Kelley MJ. T (brachyury) gene duplication confers major susceptibility to familial chordoma. Nat Genet. 2009;41(11):1176–8.CrossRefPubMedPubMedCentral Yang XR, Ng D, Alcorta DA, Liebsch NJ, Sheridan E, Li S, Goldstein AM, Parry DM, Kelley MJ. T (brachyury) gene duplication confers major susceptibility to familial chordoma. Nat Genet. 2009;41(11):1176–8.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Vujovic S, Henderson S, Presneau N, Odell E, Jacques TS, Tirabosco R, Boshoff C, Flanagan AM. Brachyury, a crucial regulator of notochordal development, is a novel biomarker for chordomas. J Pathol. 2006;209(2):157–65.CrossRefPubMed Vujovic S, Henderson S, Presneau N, Odell E, Jacques TS, Tirabosco R, Boshoff C, Flanagan AM. Brachyury, a crucial regulator of notochordal development, is a novel biomarker for chordomas. J Pathol. 2006;209(2):157–65.CrossRefPubMed
19.
Zurück zum Zitat Jo VY, Hornick JL, Qian X. Utility of brachyury in distinction of chordoma from cytomorphologic mimics in fine-needle aspiration and core needle biopsy. Diagn Cytopathol. 2014;42(8):647–52.CrossRefPubMed Jo VY, Hornick JL, Qian X. Utility of brachyury in distinction of chordoma from cytomorphologic mimics in fine-needle aspiration and core needle biopsy. Diagn Cytopathol. 2014;42(8):647–52.CrossRefPubMed
20.
Zurück zum Zitat Young VA, Curtis KM, Temple HT, Eismont FJ, DeLaney TF, Hornicek FJ. Characteristics and patterns of metastatic disease from chordoma. Sarcoma. 2015;2015:517657.CrossRefPubMedPubMedCentral Young VA, Curtis KM, Temple HT, Eismont FJ, DeLaney TF, Hornicek FJ. Characteristics and patterns of metastatic disease from chordoma. Sarcoma. 2015;2015:517657.CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Fourney DR, Gokaslan ZL. Current management of sacral chordoma. Neurosurg Focus. 2003;15(2):E9.CrossRefPubMed Fourney DR, Gokaslan ZL. Current management of sacral chordoma. Neurosurg Focus. 2003;15(2):E9.CrossRefPubMed
22.
Zurück zum Zitat Nemzek WR, Hecht S, Gandour-Edwards R, Donald P, McKennan K. Perineural spread of head and neck tumors: how accurate is MR imaging? AJNR Am J Neuroradiol. 1998;19(4):701–6.PubMed Nemzek WR, Hecht S, Gandour-Edwards R, Donald P, McKennan K. Perineural spread of head and neck tumors: how accurate is MR imaging? AJNR Am J Neuroradiol. 1998;19(4):701–6.PubMed
23.
Zurück zum Zitat Sebro R, DeLaney TF, Hornicek F, Schwab J, Choy E, Nielsen GP, Rosenthal DI. Frequency and risk factors for additional lesions in the axial spine in subjects with chordoma: indications for screening. Spine (Phila Pa 1976). 2017;42(1):E37-E40.CrossRefPubMed Sebro R, DeLaney TF, Hornicek F, Schwab J, Choy E, Nielsen GP, Rosenthal DI. Frequency and risk factors for additional lesions in the axial spine in subjects with chordoma: indications for screening. Spine (Phila Pa 1976). 2017;42(1):E37-E40.CrossRefPubMed
Metadaten
Titel
Multicentric Chordoma
An Uncommon and Incompletely Understood Presentation
verfasst von
Jason R. Jones
Anita Huttner
Ajay Malhotra
Publikationsdatum
01.08.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Clinical Neuroradiology / Ausgabe 2/2018
Print ISSN: 1869-1439
Elektronische ISSN: 1869-1447
DOI
https://doi.org/10.1007/s00062-017-0610-z

Weitere Artikel der Ausgabe 2/2018

Clinical Neuroradiology 2/2018 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.